Ishita Drugs and Industries Limited
BSE: ISHITADR.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Jagdishprasad Gokulchand Agrawal
- Employees
- 17
- Headquarters
- Ahmedabad, India
- IPO year
- 2024
- Market cap
- ₹248.2M
- Website
- http://www.ishitadrugs.com
Loading ISHITADR…
Loading profile data…Frequently asked questions about ISHITADR
What does Ishita Drugs and Industries Limited (ISHITADR.BO) do?
Ishita Drugs & Industries Ltd. engages in the manufacturing of basic drugs. It offers active pharma ingredients, drug intermediates, fine chemicals, and finished dosage forms. The company was founded by Jagdishprasad Gokulchand Agrawal on February 5, 1992 and is headquartered in Ahmedabad, India.
Where does ISHITADR.BO trade?
Ishita Drugs and Industries Limited (ISHITADR.BO) trades on the Bombay Stock Exchange.
What sector is ISHITADR.BO in?
Ishita Drugs and Industries Limited (ISHITADR.BO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Ishita Drugs and Industries Limited?
Jagdishprasad Gokulchand Agrawal is the chief executive officer of Ishita Drugs and Industries Limited (ISHITADR.BO).
Where is Ishita Drugs and Industries Limited headquartered?
Ishita Drugs and Industries Limited is headquartered in India.
Does ISHITADR.BO pay a dividend?
Ishita Drugs and Industries Limited (ISHITADR.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ISHITADR.BO go public?
Ishita Drugs and Industries Limited (ISHITADR.BO) completed its initial public offering in 2024.